Anti-TNF-α Antibody (Infliximab) Therapy Supports the Recovery of eNOS and VEGFR2 Protein Expression in Endothelial Cells
2011
The aim of this study is to investigate the effect of sera obtained from patients of Crohn's disease treated by anti-TNF-α antibody (infliximab) on the expression of endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor receptor-2 (VEGFR2) protein in human umbilical vein endothelial cells (HUVEC) cultured in vitro. HUVEC was cultured in the presence of sera derived from patients before and after treatment, or from healthy individuals. Effects of sera on the expression of eNOS and VEGFR2 were monitored by determination of mRNA and protein levels using real time quantitative PCR and Western blot analysis, respectively. The serum of Crohn's patients contained elevated levels of TNF-α (34±1.80 pg/mL), which resulted in a decrease in the protein level of eNOS in HUVEC with a simultaneous induction of VEGFR2. Infliximab treatment normalized the expression level of these proteins by decreasing TNF-α level, particularly in those cases when clinical healing was also recorded, and it also ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
13
Citations
NaN
KQI